Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation
about
Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiationPrognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomasTargeting Cell Survival Proteins for Cancer Cell DeathTargeting the Bcl-2 family for cancer therapyHepatocyte nuclear factor (HNF)-4alpha induces expression of endothelial Fas ligand (FasL) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis.BEX1 promotes imatinib-induced apoptosis by binding to and antagonizing BCL-2Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies.Increased paired box transcription factor 8 has a survival function in gliomaAPRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis.Antiproliferative effects of Plumbago rosea and its purified constituent plumbagin on SK-MEL 28 melanoma cell lines.Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiformeFas receptor-mediated apoptosis: a clinical application?The emergence of resistance to targeted cancer therapeutics.Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma.Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy.Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism.Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues.Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model.AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo.The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligandThe Fas counterattack: a molecular mechanism of tumor immune privilege.Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.The prognostic influence of bcl-2 in malignant gliomaMechanisms of chemoresistance to alkylating agents in malignant glioma.Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis.Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer.Corticorelin acetate injections for the treatment of peritumoral brain edema.Towards tailored therapy of glioblastoma multiforme.Enhancing radiation therapy for patients with glioblastoma.Expression of Bcl-2 and Bax in oligodendrogliomas and their relationship to apoptosis.All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation.WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721.Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line.Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics.Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells.
P2860
Q24645394-E6F8FC10-1ACB-441B-8668-8A9859D06B95Q24656634-DDB76D82-FB00-4B1B-AECB-042C0A221D14Q26765447-C1AA8FD2-518D-42D6-B5EA-032F331B75ACQ26866936-1C58CF74-240F-4242-A10A-E9E6B292376AQ30273613-1F181FF6-3B68-46A0-86F1-6A0F296CECE7Q31153995-7758F2CC-AE12-4687-ADC6-A2233727EDB9Q33208795-E850306F-1617-440A-B1A9-C7BDDB1D8646Q33589665-FF8ED613-8896-4BFA-969E-9024AF566942Q34090695-B555AB7C-81BC-437E-8286-B0957E74E44FQ34201413-AB232D94-8BE4-4C1F-B944-85F7D6343DC6Q34376564-F7AFAD0C-A58F-4D4E-812F-808C50743317Q34495634-7ADD2159-345F-4F1D-980B-CFD9DC982FF6Q34837015-F28016A3-EBEA-496F-836A-AC34D0DB6713Q35045473-1D2A1995-9ECE-4BC0-9510-7FBAF91ADCFCQ35388292-1AA8201F-0C5D-4702-A727-6E5C18D0E836Q35440540-809B60E6-EBF4-470E-BBD0-B26E2F458A23Q35454275-75EC6312-0488-4F26-87B9-2745D94C2A63Q35754052-712674D9-8A5E-4DAB-B053-9D7EECE4463FQ35763574-9B90685F-7FCC-496C-8C71-0065AC2A5323Q35782648-1148BEEC-FB46-4089-9083-681262D55280Q35788016-0B081FA6-F295-40C4-B5EE-EEBE0C47ADEDQ35848478-403EB5FD-0C93-4C1A-9B2C-A2B83D6662D7Q36367323-2D0D62F5-E3B3-4686-8BB5-ADE0CADF556FQ36437768-97D98279-742E-49BC-9D7D-1F6206C95651Q36622253-743F8765-221D-4E14-9220-7EA0641608BFQ36644672-2A498D76-6322-41F8-8EDB-A0B67BE94AC4Q36726010-9BC847EB-5C24-41CD-A351-A109750453A1Q37352852-68358CB4-D65E-4EC0-BF51-26213B3B64EEQ37452081-ACCB6F70-3A7E-4167-87B4-8A65BF348ABFQ37579233-6D64402C-6E15-4032-9193-F166CECD84C5Q37908815-957FD15E-9AC8-47F0-B63C-C48801513B22Q38101608-9226D71D-AABD-49B1-920C-13EC1068F6CBQ38466875-EAA7C0A5-A402-423B-A604-9D2D138EDFEDQ38743508-81DA9995-F6A8-4704-8CC5-3633BD81DBC4Q39324481-EB17FD19-0A8D-4EEB-A254-FD505040B568Q39463690-56B33407-B97E-4B7E-AC50-AB33880FF4C2Q39472965-953451D7-69AF-423E-8DD2-37EE209DC30FQ39994467-5FB126A8-D746-4585-8ABA-72225C8DFE77Q40513940-8EFE132E-8052-4280-8025-1CE962CE8D6AQ40644803-E21E6947-1020-4D0B-ADFA-9D4B0EC050FA
P2860
Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@ast
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@en
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@nl
type
label
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@ast
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@en
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@nl
prefLabel
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@ast
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@en
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@nl
P2093
P2860
P356
P1476
Protooncogene bcl-2 gene trans ...... gs and therapeutic irradiation
@en
P2093
P2860
P304
P356
10.1172/JCI117965
P407
P577
1995-06-01T00:00:00Z